This study is a multicenter, randomized, non-inferiority, parallel-group clinical trial designed to evaluate the efficacy and safety of esketamine compared with electroconvulsive therapy (ECT) in the treatment of suicidal ideation during depressive episodes in patients with mood disorders. Furthermore, it aims to investigate the potential mechanisms underlying the anti-suicidal effects of esketamine.
Phase:
NA
Details
Lead Sponsor:
Capital Medical University
Collaborators:
Beijing Chaoyang District Third Hospital Beijing Daxing District Xinkang Hospital Inner Mongolia Autonomous Region Mental Health Center The Second People's Hospital of Dali Bai Autonomous Prefecture Wuhu Fourth People's Hospital